August 15, 2022
Over-the-Counter Hearing Aids: What You Need to Know
Approximately 1 in 7 American adults struggle with hearing loss. The FDA just established a new OTC category — what does that mean for patients?
Read more
Earlens, the privately held medical-technology company committed to transforming the hearing experience, today announced that J. Connon Samuel has joined the organization as Chief Operating Officer.
Samuel was most recently Chief Operating Officer of Audigy Medical and Audigy Group, one of the fastest-growing practice-development companies for Otolaryngology, Neurotology, and Audiology private practices focusing on hearing-aid dispensing.
“Connon brings a proven track record of 12 years in the hearing-healthcare industry and over 20 years of experience bringing new business models to market and developing people, processes, and products that drive highly impactful and scalable results.”
— Bill Facteau, CEO, Earlens
Samuel's appointment is the most recent in Earlens' leadership-team expansion, aimed at supporting the upcoming launch of its new Earlens® Contact Hearing Solution.
Approximately 1 in 7 American adults struggle with hearing loss. The FDA just established a new OTC category — what does that mean for patients?
Time Magazine recognizes the revolutionary Earlens® Contact Hearing Solution among its Best Inventions of 2020.
US ENT Partners enters into a collaborative partnership with Earlens to further support ENT practices around the country.